The synthesis of N,N'-bis(3,4-dihydroxybenzylidene)-1,2-diaminobenzene was carried out according to literature 1, the stoichiometric amount of 3,4-dihydroxybenzaldehyde (2.75 g, 0.020 mol) dissolved in methanol (25 ml) is added drop by drop to phenylene-1,2-diamine solution (1.08 g, 0.010 mol in 25 ml methanol). The contents were refluxed at 70 °C for 4 h and a bright yellow precipitate was obtained. The yellow precipitate was separated by filtration, washed and dried in vacuum, yield= 87%. This compound was characterized by high-resolution mass spectrometry (HRMS) and 1 H and 13 C NMR spectroscopy. 1 H and 13 C NMR spectra were recorded on Varian Mercury 300 (Varian, USA) or Bruker Avance 400 (Bruker, Switzerland). Chemical shifts were reported as δ values relative to the internal standard tetramethylsilane. 71, 147.24, 145.51, 145.47, 144.65, 142.72, 135.96, 127.81, 122.09, 121.89, 121.11, 120.43, 118.81, 117.18, 116.69, 115.77, 115.65, 113.50, 111.04 A similar procedure was used to prepare compound 2 in 90% conversion. 1 yield= 87% 1 H-NMR (300 MHz, d 6 -DMSO) δ = 12.88 (s, 1 H); 9.37 (br, 2 H); 8.95 (br, 2 H); 7.80 (m, 1 H); 7.72 (m, 1 H); 7.47 (m, 1H); 7.22 (s, 1 H); 7.04 (t, J = 6.6 H Z , 1 H); 6.87 (t, J = 10.2 H Z , 1H); 6.63 (t, J = 7.2 H Z , 1H); 6.37 (t, J = 8.1H Z , 2 H); 5.44 (s, 1 H); 5.40 (s, 1 H).
Synthesis of N,N'-bis(3,4-dihydroxybenzylidene)-1,4-diaminobenzene (compound 2)
13 C-NMR (75 MHz, d 6 -DMSO) δ = 168. 69, 157.06, 148.70, 148.36, 146.73, 146.21, 145.41, 128.14, 125.17, 124.80, 124.05, 121.62, 121.22, 119.33, 119.10, 117.64, 117.35, 116.55, 115.00, 113.97, 113.51 Biotin-NH 2 (28.6 mg, 0.1 mmol) and compound 4 (58.8 mg, 0.15 mmol) were dissolved into 3 mL anhydrous DMF in a round-bottom flask with stirring.
1, 3-dicyclohexylcarbodiimide (DCC, 37.1 mg, 0.18 mmol) was added, and the solution was stirred for 24 h at room temperature. The formed dicyclohexylurea was filtered off, most of the solvents were evaporated, and the residue precipitated into excess isopropanol. The yellow precipitate was filtered and washed with isopropanol three times to give a off white powder, yield = 70%. 92, 172.67, 166.95, 163.19, 146.03, 145.97, 145.93, 145.10, 120.86, 117.52, 117.11, 116.29, 116.12, 116.06, 111.03, 110.94, 104.42, 99.98, 62.48, 61.43, 59.65, 55.83, 47.79, 35.69, 28.66, 28.49, 28.28, 25.95, 25.67 Figure S4 . a-c) CD melting of Pu27 DNA curves in the presence of different concentration potassium chloride buffer (a.100 mM KCl, b.50 mM KCl, c. 5 mM KCl) and incubation with compound 1 and tyrosinase (400 Units) at 37 °C for 1 h in KCl buffer, as monitored by the CD intensity at 265 nm. d) CD spectra of Pu27 DNA (20 μM) in 10 mM Tris/HCl 100 mM KCl buffer at pH 7.0 or incubation with compound 1 ([compound 1] / [DNA strand] = 5) and tyrosinase (400 Units) in 10 mM Tris/HCl 100 mM KCl buffer at pH 7.0 at 37 °C for 1 h.
Pu27 DNA Alkylated Property induced by compound 1 in 100 mM KCl Supplementary Figure S5 . Concentration dependence of compound 1 for tyrosinase oxidation DNA alkylating were incubated with 5'-end TAMRA labeled Pu27 DNA in 10 mM Tris/HCl and 100 mM KCl buffer at pH 7.0 for 1h at 37 °C. The amounts of labeled DNA and tyrosinase were fixed as 10 pmol and 40 Units, respectively. Lane 1-3 are control lanes, lane 4-11 are increasing concentrations of compound 1 (10 μM, 20 μM, 50 μM, 0.1 mM, 0.2 mM, 0.5 mM, 1 mM, 2 mM) incubation with labeled Pu27 DNA and tyrosinase (40 Units). The alkylated oligo was separated from the nonreacted DNA by 20% denaturing polyacrylamide gel. and tyrosinase were fixed at 500 μM, 1 mM, and 40 units, respectively. (1) compound 1 + MBTH incubation at 37 °C for 1 h; (2) compound 1 + tyrosinase incubation at 37 °C for 1 h; (3) MBTH + tyrosinase incubation at 37 °C for 1 h; (4) compound 1 + MBTH + tyrosinase incubation at 37 °C for 15 min; (4) compound 1 + MBTH + tyrosinase incubation at 37 °C for 0.5 h; (4) compound 1 + MBTH + tyrosinase incubation at 37 °C for 1 h.
CD spectra and CD meiting spectrum of Pu27 DNA induced by active drug (intermediate o-quinones form) of compound 1
In order to simulate the intracellular tyrosinase oxidative environment, compound 1 was incubated with tyrosinase (400 Units) at 37 °C for 1 h and then incubated with Pu27 DNA at 37 °C for another 1 h to make sure the intermediate o-quinones form was completely generated. 
Cell culture.
B16-F1 cells and Hela cells were incubated in Dulbecco's modified Eagle's Medium (DMEM, Gibco, USA), supplemented with 10% fetal bovine serum (Hangzhou Sijiqing Biological engineering Materials Corporation), 100 Units / mL penicillinstreptomycin (Invitrogen, USA) and incubated at 37 °C in a 95%
humidified atmosphere containing 5% CO 2 . All measurements were performed at room temperature.
Long term cell culture studies.
Cells were grown in T25 tissue culture flask at 10 5 /flask. Compound 1 with increasing concentrations of 20, 40 and 50 μM which containing DMEM were added 24 h after seeding. All samples of control and drug-exposed ones were counted and reseeded at 10 5 /flask every two days. Drug exposure process continued until cell proliferation almost inhibited. The duration was about six days. Figure S21 . UV thermal difference spectrum (TDS) factors ΔA 240nm /ΔA 295nm over a temperature range. Each individual PQS (10 μM) which was incubated with compound 1a (100 μM) and tyrosinase (400 Units) in the absence of potassium chloride (black squares) or compound 1a (100 μM) and tyrosinase (400 Units) in potassium chloride (100 mM ) containing buffer (red dots). For parallel quadruplexes, the magnitudes for this TDS factor appear above 4, and for antiparallel or hybrid quadruplexes below 2, These results are corresponding to the CD results.
B16-F1 cell proliferation inhibition

NMR spectra of the PQS78 and PQS119 identified in B16-F1 cells
NMR for DNA were performed on Bruker Avance Ⅲ 800 or Bruker AscendTM 600 with TXI CyroProbeTM (Bruker, Switzerland). X. laevis were purchased from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (China). 
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